BRCA1 and breast carcinoma: To sum up, the phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway is stimulated by estrogen in the ER-negative BRCA1-deficient breast cancer cells and leads to enhanced tumor growth [74].